Effects of Sodium, Lithium, and Magnesium on in Vitro Binding of [3H]SCH23390 in Rat Neostriatum and Cerebral Cortex
Overview
Authors
Affiliations
The effects of sodium, lithium, and magnesium on the in vitro binding properties of the D1 antagonist [3H]SCH23390 were examined with membrane preparations from rat neostriatum (CPU; caudate-putamen) and cerebral cortex (CTX). The saturation binding isotherms for both tissues performed in the presence of 120 mM of either Na+ or Li+ revealed an increase in the affinity, as compared to that observed when the incubation buffer was composed of Tris-Cl 50 mM with MgCl2 1 mM alone. For the CPU there were no changes in the maximum binding capacity (Bmax) in the different buffers used. In the case of the CTX, there was a loss of [3H]SCH23390 binding sites when either Na+ or Li+ 120 mM were added to the incubations, suggesting a lack of selectivity of this ligand in the absence of group IA cations. The agonist state of the [3H]SCH23390 binding site was studied in competition experiments with dopamine. The highest agonist affinity was obtained in 50 mM Tris-Cl buffer with 1 mM MgCl2 while the addition of 120 mM of either Na+ or Li+ caused a 3- to 5-fold decrease in the potency of dopamine to compete with specific [3H]SCH23390 binding in both CPU and CTX. The presence of magnesium was essential for the competition experiments; i.e.: a concentration of 1 mM MgCl2 was optimum to obtain dopamine antagonism of ligand binding, while increasing Mg2+ to 2 or 5 mM did not appear to further improve the inhibitions. The results support both agonist and antagonist affinity shifts for the dopamine D1 receptor labeled with [3H]SCH23390.(ABSTRACT TRUNCATED AT 250 WORDS)
Down-regulation of beta-adrenergic and dopaminergic receptors induced by 2-phenylethylamine.
Paetsch P, Greenshaw A Cell Mol Neurobiol. 1993; 13(3):203-15.
PMID: 8242685 PMC: 11566813. DOI: 10.1007/BF00733750.
Reader T, Grondin L, MONTREUIL B, Dewar K Naunyn Schmiedebergs Arch Pharmacol. 1989; 340(6):617-25.
PMID: 2575710 DOI: 10.1007/BF00717736.
Paetsch P, Greenshaw A Cell Mol Neurobiol. 1992; 12(6):597-606.
PMID: 1490276 PMC: 11567202. DOI: 10.1007/BF00711239.
Comparative biochemical pharmacology of central nervous system dopamine D1 and D2 receptors.
Reader T, Molina-Holgado E, Dewar K Mol Neurobiol. 1992; 6(4):425-50.
PMID: 1285933 DOI: 10.1007/BF02757945.